|
EP1807087A2
|
|
Inhibitors of acetylcholinesterase for treating skin diseases
|
|
GB0504202D0
|
|
Method of treating skin diseases
|
|
GB0422634D0
|
|
Acetylcholinesterase inhibitors for the treatment of skin
|
|
WO9729750A1
|
|
Treatment of arthritis disorders, rheumatoid arthritis and manifestations associated with rheumatoid disorders
|
|
DK138292D0
|
|
Improvements in withdrawal treatment
|
|
NZ242744A
|
|
Use of a cholinesterase inhibitor (eg a galanthamine derivative) for treating fatigue
|
|
US5336675A
|
|
Method of treating mania in humans
|
|
CA2062094A1
|
|
Method of treating mania
|
|
DK18192D0
|
|
Method of Treating chronic fatigue syndrome
|
|
DK18292D0
|
|
Method of Counteracting adverse effects of benzodiazepines
|
|
DK18392D0
|
|
Method of Treating mania
|
